Cargando…

An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis

BACKGROUND: In [(99m)Tc]Tc-DPD scintigraphy for myocardial ATTR amyloidosis, planar images 3 hour p.i. and SPECT/CT acquisition in L-mode are recommended. This study investigated if earlier planar images (1 hour p.i.) are beneficial and if SPECT/CT acquisition should be preferred in H-mode (180° det...

Descripción completa

Detalles Bibliográficos
Autores principales: Schatka, Imke, Bingel, Anne, Schau, Franziska, Bluemel, Stephanie, Messroghli, Daniel R., Frumkin, David, Knebel, Fabian, Diekmann, Sonja M., Elsanhoury, Ahmed, Tschöpe, Carsten, Hahn, Katrin, Amthauer, Holger, Rogasch, Julian M. M., Wetz, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709821/
https://www.ncbi.nlm.nih.gov/pubmed/34331215
http://dx.doi.org/10.1007/s12350-021-02715-6
_version_ 1784623027914276864
author Schatka, Imke
Bingel, Anne
Schau, Franziska
Bluemel, Stephanie
Messroghli, Daniel R.
Frumkin, David
Knebel, Fabian
Diekmann, Sonja M.
Elsanhoury, Ahmed
Tschöpe, Carsten
Hahn, Katrin
Amthauer, Holger
Rogasch, Julian M. M.
Wetz, Christoph
author_facet Schatka, Imke
Bingel, Anne
Schau, Franziska
Bluemel, Stephanie
Messroghli, Daniel R.
Frumkin, David
Knebel, Fabian
Diekmann, Sonja M.
Elsanhoury, Ahmed
Tschöpe, Carsten
Hahn, Katrin
Amthauer, Holger
Rogasch, Julian M. M.
Wetz, Christoph
author_sort Schatka, Imke
collection PubMed
description BACKGROUND: In [(99m)Tc]Tc-DPD scintigraphy for myocardial ATTR amyloidosis, planar images 3 hour p.i. and SPECT/CT acquisition in L-mode are recommended. This study investigated if earlier planar images (1 hour p.i.) are beneficial and if SPECT/CT acquisition should be preferred in H-mode (180° detector angle) or L-mode (90°). METHODS: In SPECT/CT phantom measurements (NaI cameras, N = 2; CZT, N = 1), peak contrast recovery (CRpeak) was derived from sphere inserts or myocardial insert (cardiac phantom; signal-to-background ratio [SBR], 10:1 or 5:1). In 25 positive and 38 negative patients (reference: endomyocardial biopsy or clinical diagnosis), Perugini scores and heart-to-contralateral (H/CL) count ratios were derived from planar images 1 hour and 3 hour p.i. RESULTS: In phantom measurements, accuracy of myocardial CRpeak at SBR 10:1 (H-mode, 0.95-0.99) and reproducibility at 5:1 (H-mode, 1.02-1.14) was comparable for H-mode and L-mode. However, L-mode showed higher variability of background counts and sphere CRpeak throughout the field of view than H-mode. In patients, sensitivity/specificity were ≥ 95% for H/CL ratios at both time points and visual scoring 3 hour. At 1 hour, visual scores showed specificity of 89% and reduced reader’s confidence. CONCLUSIONS: Early DPD images provided no additional value for visual scoring or H/CL ratios. In SPECT/CT, H-mode is preferred over L-mode, especially if quantification is applied apart from the myocardium. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02715-6.
format Online
Article
Text
id pubmed-8709821
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87098212022-01-10 An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis Schatka, Imke Bingel, Anne Schau, Franziska Bluemel, Stephanie Messroghli, Daniel R. Frumkin, David Knebel, Fabian Diekmann, Sonja M. Elsanhoury, Ahmed Tschöpe, Carsten Hahn, Katrin Amthauer, Holger Rogasch, Julian M. M. Wetz, Christoph J Nucl Cardiol Original Article BACKGROUND: In [(99m)Tc]Tc-DPD scintigraphy for myocardial ATTR amyloidosis, planar images 3 hour p.i. and SPECT/CT acquisition in L-mode are recommended. This study investigated if earlier planar images (1 hour p.i.) are beneficial and if SPECT/CT acquisition should be preferred in H-mode (180° detector angle) or L-mode (90°). METHODS: In SPECT/CT phantom measurements (NaI cameras, N = 2; CZT, N = 1), peak contrast recovery (CRpeak) was derived from sphere inserts or myocardial insert (cardiac phantom; signal-to-background ratio [SBR], 10:1 or 5:1). In 25 positive and 38 negative patients (reference: endomyocardial biopsy or clinical diagnosis), Perugini scores and heart-to-contralateral (H/CL) count ratios were derived from planar images 1 hour and 3 hour p.i. RESULTS: In phantom measurements, accuracy of myocardial CRpeak at SBR 10:1 (H-mode, 0.95-0.99) and reproducibility at 5:1 (H-mode, 1.02-1.14) was comparable for H-mode and L-mode. However, L-mode showed higher variability of background counts and sphere CRpeak throughout the field of view than H-mode. In patients, sensitivity/specificity were ≥ 95% for H/CL ratios at both time points and visual scoring 3 hour. At 1 hour, visual scores showed specificity of 89% and reduced reader’s confidence. CONCLUSIONS: Early DPD images provided no additional value for visual scoring or H/CL ratios. In SPECT/CT, H-mode is preferred over L-mode, especially if quantification is applied apart from the myocardium. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02715-6. Springer International Publishing 2021-07-30 2021 /pmc/articles/PMC8709821/ /pubmed/34331215 http://dx.doi.org/10.1007/s12350-021-02715-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Schatka, Imke
Bingel, Anne
Schau, Franziska
Bluemel, Stephanie
Messroghli, Daniel R.
Frumkin, David
Knebel, Fabian
Diekmann, Sonja M.
Elsanhoury, Ahmed
Tschöpe, Carsten
Hahn, Katrin
Amthauer, Holger
Rogasch, Julian M. M.
Wetz, Christoph
An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
title An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
title_full An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
title_fullStr An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
title_full_unstemmed An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
title_short An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
title_sort optimized imaging protocol for [(99m)tc]tc-dpd scintigraphy and spect/ct quantification in cardiac transthyretin (attr) amyloidosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709821/
https://www.ncbi.nlm.nih.gov/pubmed/34331215
http://dx.doi.org/10.1007/s12350-021-02715-6
work_keys_str_mv AT schatkaimke anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT bingelanne anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT schaufranziska anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT bluemelstephanie anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT messroghlidanielr anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT frumkindavid anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT knebelfabian anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT diekmannsonjam anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT elsanhouryahmed anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT tschopecarsten anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT hahnkatrin anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT amthauerholger anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT rogaschjulianmm anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT wetzchristoph anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT schatkaimke optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT bingelanne optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT schaufranziska optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT bluemelstephanie optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT messroghlidanielr optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT frumkindavid optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT knebelfabian optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT diekmannsonjam optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT elsanhouryahmed optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT tschopecarsten optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT hahnkatrin optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT amthauerholger optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT rogaschjulianmm optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis
AT wetzchristoph optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis